Medici di Oncologia all'estero — Pagina 14

Dr. Joseba Rebollo Liceaga is a clinical oncologist at Quirónsalud Alicante. He focuses on personalized cancer treatments and gene-based therapies for metastatic breast cancer. Dr. Rebollo Liceaga teaches as a professor of Multidisciplinary and Personalized Oncology. He treats various conditions, including prostate, colon, and thyroid cancers.

• Former Head of Oncology at Clínica San Miguel and Hospital General de Villalba.
• Researches electrochemotherapy and multidisciplinary approaches for complex cases.
• Practices at JCI-accredited Quirónsalud Torrevieja, a leading center in southeastern Spain.
• Expert in diagnostics using PET-CT, mammography, and tumor marker blood tests.

Dr. Tarek M. Hashem is an associate professor and specialist in surgical oncology. He treats breast cancer at Shefaa Al Orman International Oncology Hospitals in Egypt. Dr. Hashem completed breast surgery fellowships in Germany at Marienhospital Düsseldorf and Heidelberg University Hospital. He is a member of the Royal College of Surgeons of England (MRCS).

• Specializes in oncoplastic surgery and complex breast reconstruction after tumor removal.
• Performs flap reconstructions including LD, TRAM, and SEAP techniques.
• Uses supermicrosurgery for the management of lymphedema.
• Practices at an ESMO-accredited oncology center that treats 6,000 patients annually.

Dr. Tamer Mostafa Manie is an Associate Professor of Surgical Oncology at Cairo University. He is a consultant at the ESMO-accredited Shefaa Al Orman Hospital. Dr. Manie specializes in breast cancer surgery and reconstruction. He integrates oncological removal with cosmetic techniques to preserve breast appearance.

• Completed training at the Nottingham Breast Institute and the European Institute of Oncology.
• Performs complex reconstructions using silicone implants, tissue expanders, and flap options.
• Uses supermicrosurgery to treat lymphedema.
• Former Chairman of the Breast Cancer MDT at Madinet Nasr Oncology Center.
• Member of the European Society of Surgical Oncology.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Dr. Kurt Rasche is a German pulmonologist with more than 40 years of clinical experience. He is Chief of Pulmonology at Helios University Hospital Wuppertal. He leads the departments of pulmonology, sleep medicine, and ventilation therapy. He also heads the certified Lung Cancer Center.

He is certified in internal medicine, pulmonology, allergology, sleep medicine, and intensive care. His clinical work focuses on diagnosing and treating chronic lung diseases, lung cancer, and sleep-related breathing disorders. He works closely with specialists from other fields to provide coordinated care.

Dr. Rafał Marszałek is a general, oncologic, and bariatric surgeon. He specializes in minimally invasive and laparoscopic techniques. He leads the General Surgery Department at the Hospital in Legionowo, affiliated with the Military Medical Institute. He has many years of clinical experience from leading centers in Warsaw and the region.

As department head, he applies current treatment standards and advances modern surgical practice. The unit performs a high volume of procedures each year and provides full perioperative care. His key focus is bariatric surgery. He manages patient qualification, selects tailored laparoscopic methods, and provides postoperative monitoring. The goal is durable weight loss and reduced obesity‑related risk. His work also includes hernia repair, gallbladder surgery, thyroid and parathyroid surgery, breast surgery, and oncologic procedures.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Dr. Amr Mahmoud Al Demery is a consultant thoracic surgical oncologist at Shefaa Al Orman Hospital. He specializes in the diagnosis and surgical treatment of thoracic cancers. Dr. Al Demery is a Member of the Royal College of Surgeons of England. He holds a Doctorate in Surgical Oncology from the National Cancer Institute.

• Cofounder and member of the Egyptian Society of Respiratory Neoplasms.
• Performs complex lung resections, including lobectomy and pneumonectomy.
• Expert in esophageal cancer surgery and chest wall reconstruction.
• Works at an ESMO-accredited center treating 6,000 patients annually.

Specializations

Cancer Surgery

Pancreatic Surgery

Bile Duct Surgery

Bariatric Metabolic Surgery

Oncological Surgery

Breast Surgery

Gastric cancer

Colon cancer

Thyroid Cancer

Obesity Surgery

Diabetes Surgeries

Dr. Hisham Khalifa is a consultant surgical oncologist at Shefaa Al Orman International Oncology Hospitals. He specializes in the surgical management of ovarian, uterine, and cervical cancers. Dr. Khalifa is a Fellow of the American College of Surgeons (FACS). He uses both laparoscopic and open surgical techniques for gynecological oncology cases.

• Director of the professional Gyne-Onco surgery diploma at the National Cancer Institute.
• Fellow of the European Board of Surgery (UEMS).
• Member of the European Society of Surgical Oncology (ESSO).
• Former assistant professor of surgery at AlFaisal University in Riyadh.

Dr. Kasama Wiroskoolchai is a wellness specialist at Mali Interdisciplinary Hospital in Bangkok. Dr. Wiroskoolchai focuses on combining conventional and precision medicine to treat chronic conditions. The doctor manages non-communicable diseases like type 1 and type 2 diabetes. This approach aims to improve quality of life and longevity through restorative care.

• Specializes in pharmacopuncture and rehabilitation after stroke or traumatic brain injury.
• Treats autoimmune conditions, including rheumatoid arthritis and autoimmune hepatitis.
• Works at a facility accredited by the GHA and AACI for international patient safety.
• Uses regenerative techniques to help tissue repair and prevent disease complications.

Assoc. Prof. Dr. Mehmet Salih İyikesici is a medical oncologist. He provides personalized care for breast, lung, and gastrointestinal cancers. He combines metabolically supported therapies with chemotherapy. His interests include the ketogenic diet in cancer care, hyperthermia, and hyperbaric oxygen therapy.

He has conducted and contributed to national and international scientific studies. Selected national peer-reviewed publications include Metabolic Supported Chemotherapy in Rectal Cancer (2020), NSCLC Patient Outcomes – Marmara University (2004), and Early-Stage Breast Cancer Outcomes (2004).

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.